Abstract
Opiates, a large class of “morphine-like” drugs, exert a large range of pharmacological effects, in addition to analgesia. The heterogeneity of effects among opiates has been well known for many years. Most notable in this regard are the properties of the mixed agonist-antagonist opiates of the benzomorphan series. These compounds have been of special interest because of the desirability of developing a drug having morphine-like analgesic effects but lacking addictive potential. Cyclazocine, SKF-10,047 (N-allylnor-cyclazocine), and related drugs of the benzomorphan group differ from classical opiates in displaying psychotomimetic effects in humans and unique behavioral effects in animals (Haertzen, 1970; Holtzman, 1979). The syndromes associated with many of the benzomorphans depend dramatically on the species and vary qualitatively with the dose administered. At low doses many of these drugs produce effective analgesia in humans (Lasagna, 1954; Keats, 1964). In addition, they may clinically antagonize the analgesic and respiratory-depressant effects of classical opiates (Harris, 1964), precipitate a withdrawal syndrome in morphine-addicted patients, and prevent development of addiction to morphine (Martin, 1965). At the same time, these opiates may produce physical dependence when administered alone and a characteristic withdrawal syndrome differing from that of morphine upon drug cessation (Martin, 1965).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chang K-J, Cooper BR, Hazum E and Cuatrecasas P: Multiple opiate receptors: Different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol Pharmacol 16:91–104, 1979
Chang K-J and Cuatrecasas P: Multiple opiate receptors; enkephalins and morphine bind to receptors of different specificity. J Biol Chem 254:2610–2618, 1979
Chang K-J, Hazum E and Cuatrecasas P: Possible role of distinct morphine and enkephaline receptors in mediating actions of benzomorphan drugs (putative K and σ receptors). Proc Nat Acad Sci USA 77:4469–4473, 1980
Chang K-J, Miller RJ and Cuatrecasus P: Interaction of enkephalin with opiate receptors in intact cultured cells. Mol Pharmacol 14:961–970, 1978
Chen G, Ensor CR, Russell D and Bohner B: The pharmacology of 1-(1-phenylcyclohexyl) piperidine. HCl. J Pharmacol Exp Ther 127:241–250, 1959
Corssen G and Domino EE: Dissociative anesthesia: Further pharmacologic studies and first clinical experience with phencyclidine derivative C1-581. Anesth Analg 45:29–40, 1965
Evans JM, Hogg MI, Lunn JN and Rosen M: Degree and duration by naloxone of effects of morphine in conscious subjects. Br Med J 2:589–591, 1974
Gilbert PE and Martin WR: The effects of morphine- and nalorphine-like drugs in the nondependent, morphine dependent and cyclazocine dependent chronic spinal dog. J Pharmacol Exp Therap 198:66–82, 1976
Goodman R, Snyder SH, Kuhar MJ and Young WS III: Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Nat Acad Sci USA 77:6239–6243, 1980
Griefenstein FE, DeVault M, Yoshitake MD and Cajewski JE: A study of a 1-arylcyclohexylamine for anesthesia. Anesth Analg 37:283–294, 1958
Haertzen CR: Subjective effects of narcotic antagonists cyclazocine and nalorphine on the addiction research center inventory (ARCI). Psychopharmacologia 18:366–377, 1970
Harris RA: Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled bheavior. J Pharmacol Exp Ther 213:497–503, 1980
Harris LS and Pierson AK: Some narcotic antagonists in the benzomorphan series. J Pharmacol Exp Ther 143:141–148, 1964
Hiller JM and Simon EJ: 3H-ethylketocyclazocine binding: Lack of evidence for a separate K receptor in rat CNS. Eur J Pharmacol 60:389–390, 1979
Holtzman SG: Narcotic antagonists as stimulants of behavior in the rat: Specific and nonspecific effects. In: MC Braude et al (eds.), Narcotic Antagonists. New York: Raven Press, pp 371–382, 1979
Holtzman SG: Phencyclidine-like discriminative effects of opioids in the rat. J Pharmacol Exp Ther 1981 (in press)
Holtzman SG and Jewett RE: Stimulation of behavior in the rat by cyclazocine: Effects of naloxone. J Pharmacol Exp Ther 187:380–390, 1973
Jasinski DR, Martin WR and Sapira JD: Antagonism of the subjective effects, behavioral, pupillary and respiratory depressant effects of cyclazocine by naloxone. Clin Pharmacol Ther 9:215–222, 1968
Keats AS and Telford J: RF Gould (ed.), Narcotic Antagonists as Analgesics: Chemical Aspects in Molecular Modifications in Drug Design. Washington, DC: American Chemical Society, 1964
Killam KF Jr, Brocco MJ and Robinson CA: Evaluation of narcotic and narcotic antagonist interactions in primates. Ann NY Acad Sci 281:331–335, 1976
Kosterlitz HW, Lord JAH, Paterson SJ and Waterfield AA: Effect of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with μ- and δ-receptors. Br J Pharmacol 68:33–342, 1980
Kosterlitz HW and Paterson W: Characterization of opioid receptors in nervous tissue. Proc R Soc Lond 210:113–122, 1980
Kream RM and Zukin RS: Binding characteristics of a potent enkephalin analog. Biochem Biophys Res Commun 90:99–109, 1979
Lasagna L and Beecher HK: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J Pharmacol Exp Ther 112:356–363, 1954
Leslie FM, Chavkin C and Cox BM: Ligand specificity of opioid binding sites in brain and peripheral tissues. In: EL Way (ed.), Endogenous and Exogenous Opiate Agonists and Antagonists. New York: Pergamon Press, pp 109–112, 1980
Lord JAH, Waterfield AA, Hughes J and Kosterlitz HW: Endogeneous opioid peptides: Multiple agonists and receptors. Nature 267:495–500, 1977
Lord JAH, Waterfield AA, Hughes J and Kosteriitz HW: HW Kosterlitz (ed.), Multiple Opiate Receptors in Opiates and Endogenous Opioid Peptides. Amsterdam: North-Holland Publishing, pp 275–280, 1976
Luisada PV: The phencyclidine psychosis: Phenomenology and treatment. In: RC Petersen and RC Stillman (eds.), Phencylidine Abuse: An Appraisal. NIDA Research Monograph 21, pp 241–253, 1978
Maayani S and Weinstein H: “Specific Binding” of 3H-phencyclidine: Artifacts of the rapid filtration method. Life Sci 26:2011–2016, 1980
Martin WR: Opioid antagonists. Pharmacol Review 19:463–521, 1967
Martin WR, Eades CG, Thompson JA, Huppler RE and Gilbert PE: The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Therap 197:517–532, 1976
Martin WR, Fraser HF, Gorodetzky CW and Rosenberg DE: Studies in the dependence producing potential of the narcotic antagonists 2-cyclopropylmethyl-2-dydroxy-5, 9 dimethyl-6,7 benzomorphan (cyclazocine, Win 20, 740, ARC II-C-3). J Pharmacol Exp Therap 150:426–436, 1965
Martin WR and Gorodetzky CW: Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine). J Pharmacol Exp Therap 150:437–442, 1965
McQuinn RL, Cone EJ, Shannon HE and Su T-P: Phencyclidine: L Structure activity relationships of the cycloalkyl ring of phencyclidine. J Med Chem 1981 (in press)
Pasternak GW: Multiple opiate receptors: 3H-ethylketocyclazocine receptor binding and ketocyclazocine analgesia. Proc Nat Acad Sci USA 77:3691–3694, 1980
Pert CB and Taylor D: EL Way (ed.), Type 1 and Type 2 Opiate Receptors in Endogenous and Exogenous Opiate Agonists and Antagonists. New York: Pergamon Press, pp 87–90, 1980
Quirion R, Hammer R, Herkenham M and Pert CB: A phencyclidine/sigma opiate receptor: Its visualization by tritium-sensitive film. Proc Nat Acad Sci USA 1981 (in press)
Robson LE and Kosteriitz HW: Specific protection of the binding sites of D-ala2-D-leu5-enkephalin (δ-receptors) and dihydromorphine (μ-receptors). Proc R Soc Lond 205:425–432, 1979
Roemer D, Buescher HH, Hill RC, Pless J, Bauer W, Cardinaux F, Closse A, Hauser D and Hyguenip R: A synthetic enzephalin analogue with prolonged parenteral and oral analgesic activity. Nature 268:547–549, 1977
Romer D, Buscher H, Hill RC, Maurer R, Petcher TJ, Welle HBA, Bakel HCCK and Akkerman AM: Bremazocine: A potent, long-acting opiate kappa agonist. Life Sci 27:971–978, 1980
Rosencrans JD, Chance WT and Spencer RM: The discriminative stimulus properties of cyclazocine: Generalization studies involving nalorphine, morphine and LSD. Res Commun Chem Pathol Pharmacol 20:221–237, 1978
Schaefer GJ and Holtzman SG: Discriminative effects of cyclazocine in the squirrel monkey. J Pharmacol Exp Ther 205:291–301, 1978
Simatov R, Childers SR and Snyder SH: The opiate receptor binding interaction of 3H-methionine enkephalin: An opioid peptide. Eur J Pharmacol 47:319–331, 1978
Smith JR and Simon EJ: Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide; evidence for two classes of opiate receptors. Proc Nat Acad Sci USA 77:281–284, 1980
Steinert HR, Holtzman SG and Jewett RE: Some agonistic actions of the morphine antagonist levallorphan on behavior and brain monoamines in the rat. Psychopharmacologia 31:35–46, 1973
Teal JJ and Holtzman SG: Discriminative stimulus effects of cyclazocine in the rat. J Pharmacol Exp Ther 212:368–376, 1980
Teal JJ and Holtzman SG: Discriminative stimulus effects of prototype opiate receptor agonists in monkeys. Eur J Pharmacol 68:1–10, 1980
Vincent JP, Kartalovski B, Geneste P, Kamenka JM and Lazdunski M: Interaction of phencyclidine (“angel dust”) with a specific receptor in rat brain membranes. Proc Nat Acad Sci USA 76:4578–4682, 1979
Vincent J-P, Vignon J, Kartalovski B and Lazdunski M: Binding of phencyclidine to rat brain membranes: Technical aspects. Eur J Pharmacol 68:73–77, 1980
Vincent J-P, Vignon J, Kartalovski B and Lazdunski M: Compared properties of central and peripheral binding sites for phencyclidine. Eur J Pharmacol 68:79–82, 1980
Waterfield AA, Smokcum RWJ, Hughes J, Kosterlitz HW and Henderson G: In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol 43:107–116, 1977
Wray SR: A correlative evaluation of cyclazocine, LSD and naloxone on continuous discriminated avoidance in rats. Psychopharmacologia 26:29–43, 1972
Zukin RS and Gintzler AR: Guanyl nucleotide interactions with opiate receptors in guinea pig brain and ileum. Brain Res 186:486–491, 1980
Zukin SR, Margolis A and Zukin RS: Biochemical Evidence for Kappa and Sigma Receptors. 1981 (in preparation) Zukin RS and Zukin SR: Demonstration of 3H-cyclazocine binding to multiple opiate receptor sites. Mol Pharm 1981 (in press)
Zukin SR and Zukin RS: Identification and characterization of 3H-phencyclidine binding to specific brain receptor sites in PCP. In: E Domino (ed.), Historical and Current Perspectives. Ann Arbor: NPP Books, 1981
Zukin SR and Zukin RS: Specific [3H] pencyclidine binding in rat central nervous system. Proc Nat Acad Sci USA 76:5372–5376, 1979
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Spectrum Publications, Inc.
About this chapter
Cite this chapter
Zukin, R.S., Zukin, S.R. (1984). Multiple Opiate Receptors. In: Serban, G. (eds) Social and Medical Aspects of Drug Abuse. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6320-0_8
Download citation
DOI: https://doi.org/10.1007/978-94-011-6320-0_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6322-4
Online ISBN: 978-94-011-6320-0
eBook Packages: Springer Book Archive